Figures
Abstract
Background
The impacts of blood pressure (BP) load on target-organ damage in patients with chronic kidney disease (CKD) are largely unclear. We examined whether BP load is correlated with target-organ damage (TOD) in Chinese CKD patients independent of BP level.
Methods
We recruited 1219 CKD patients admitted to our hospital division in this cross-sectional study. The TOD were measured by estimated glomerular filtration rate (eGFR), proteinuria, left ventricular mass index (LVMI) and carotid intima-media thickness (cIMT) in this study. Univariate and multivariate linear analyses were used to evaluate the relationship between systolic blood pressure (SBP) load, diastolic blood pressure (DBP) load and these renal, cardiovascular parameters.
Results
In multivariable-adjusted models, BP load and ambulatory BP levels both independently correlated with LVMI, eGFR and proteinuria in all groups of CKD patients (p<0.05), 24-h SBP correlated with cIMT only in non-diabetic CKD patients without hypertension (p<0.05), while nighttime SBP load was associated with cIMT only in non-diabetic CKD patients (p<0.05). Furthermore, nighttime SBP load additionally increased coefficient of determination (R2) and correlated with LVMI, proteinuria in non-diabetic CKD patients without hypertension (R2 = 0.034, P<0.001 and R2 = 0.012, P = 0.006 respectively) and LVMI, cIMT, eGFR in non-diabetic CKD patients with hypertension (R2>0.008, P<0.05) in multivariable-adjusted model which already including the 24-h BP. BP load did not refine this correlation based on the 24-h BP level in diabetic CKD patients.
Citation: Wang C, Zhang J, Deng W, Gong W, Liu X, Ye Z, et al. (2015) Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease. PLoS ONE 10(7): e0131546. https://doi.org/10.1371/journal.pone.0131546
Editor: Giuseppe Schillaci, University of Perugia, ITALY
Received: November 24, 2014; Accepted: June 3, 2015; Published: July 17, 2015
Copyright: © 2015 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: This project was supported by the National Natural Science Foundation of China (No.81300595). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Background
Chronic kidney disease (CKD) has become an important public-health issue in China. The number of patients with CKD in China is ≈119.5 million based on the fact that the prevalence of CKD in China is 10.8% [1]. Hypertension is the most prevalent independent risk factor for the progression of renal failure and cardiovascular disease [2]. Lowering blood pressure (BP) can delay the progression of CKD [3]. It is very important to assess BP accurately and completely in CKD patients.
Over the last decade, ambulatory blood pressure monitoring (ABPM) employing a wearable, oscillometric BP device to automatically measure and record BPs at prescribed intervals has emerged as a valuable tool for assessing BP. ABPM provides additional information on the mean BP (systolic and diastolic), BP load (proportion of BP readings above a threshold BP), and non-dipping (<10% decrease in night-time BP relative to daytime BP). There are many trials on ABPM and the dipper pattern [4, 5], whereas studies on BP load are very limited especially for adult patients. BP load has been suggested to be a clinically useful parameter complementing quantification of the corresponding average BP levels, which might be an index of hemodynamic burden on the cardiovascular system in addition to the information carried by average BP levels. A series of studies have set the role of BP load in subclinical organ damage in hypertensive patients: daytime systolic blood pressure (SBP) load was an independent predictor of the left ventricular mass index (LVMI) [6], night-time SBP load to have a stronger association with the LVMI [7], while diastolic blood pressure (DBP) load was an independent predictor of intima-media thickness [8]. All these studies on BP load and target-organ damage (TOD) were limited by small sample size as well as methodological problems related to ABPM and short-term follow-up, which might lead to inconsistent conclusions [9,10]. The relationship between BP load and TOD dependent on BP levels is controversial: one study involving 130 hypertensive patients showed that high 24-h SBP load might be associated, independently of the average level of 24-h SBP, with an adverse cardiovascular risk [8] while another study involving 869 individuals without therapy showed that BP load was associated with target-organ damage, but not independently of BP level [11].
The role of BP load in patients with CKD is not known. We previously found that TOD such as estimated glomerular filtration rate (eGFR), proteinuria, LVMI and carotid intima-media thickness (cIMT) were significantly related to the parameters of AMBP in Chinese CKD patients [12]. We hypothesized that BP load correlated with TOD in Chinese CKD patients based on the data stated above. We carried out this cross-sectional study to ascertain if different times of BP load were associated with TOD, and whether such an association survives after accounting for the impact of average BP levels in Chinese CKD patients.
Subjects, Materials and Methods
Study population
The study protocol was approved by the ethics committee of the Third Hospital of Sun Yat-Sen University (Guangdong, China). This cross-sectional study were from May 2010 to October 2014, all study participants provided written informed consent to be included in the study.
Inclusion criteria were: 1) consecutive CKD patients who had not undergone any type of antihypertensive treatment within 1 month; 2) pre-dialysis CKD patients with a stable disease state. Exclusion criteria were: 1) undergoing treatment with corticosteroids or hormones; 2) acute changes in the eGFR >30% in the previous three months; pregnancy; 3) history of abuse of drugs or alcohol; night work or shift-work employment; 4) acquired immunodeficiency syndrome; 5) cardiovascular disorders (unstable angina pectoris, heart failure, life-threatening arrhythmia, atrial fibrillation and grade III–IV retinopathy); 6) intolerance to ABPM; 7) inability to communicate and comply with all of the study requirements; 8) maintenance dialysis. Finally, 1219 CKD patients were enrolled in this study.
Ambulatory blood pressure monitoring
Patients underwent 24-h ABPM using a TM-2430 Monitor (A&D, Tokyo, Japan). Cuff size was chosen based on arm circumference and fixed to the non-dominant arm. BP readings were obtained in the morning at three points from 7 am to 10 pm using a mercury sphygmomanometer by a physician who did not have access to ABP values. Then BP was recorded every 15 min from 7 am to 10 pm, and every 30 min from 10 pm to 7 am. Monitoring was done on a working day. Patients were asked to attend to their usual activities but to keep motionless at the time of measurement. Patients had no access to ABP values. Strenuous physical activity was discouraged in all patients during the monitoring period, and their daily activities were comparable. BP series were eliminated from the analyses if: >30% of the measurements were lacking; they had missing data for >3-h spans; they were collected from subjects who were experiencing an irregular rest–activity schedule or a night-time sleep span <6 h or >12 h during monitoring. Night time BP was defined as the average BP from the time of patients went to bedtime until the time they got out of bed, and daytime as the average BPs recorded during the rest of the day.
Cardiac assessment.
Cardiac structure was assessed by two investigators trained for this purpose before starting the study. Left ventricular mass (LVM) were assessed using two-dimensional echocardiography. Linear measurements of end-diastolic interventricular septal wall thickness (IVSd), end-diastolic left ventricular internal dimension (LVIDd), and end-diastolic posterior wall thickness (PWTd) were obtained from M-mode tracings. LVM was calculated using the formula [13], and the left ventricular mass index (LVMI) was obtained by calculating the ratio of LVM to body surface area [14].
Carotid ultrasonography.
Carotid intima-media thickness (cIMT) was assessed by two trained investigators before study commencement. A SonoSite MicroMaxx Ultrasound System paired with a 5–10-MHz Multifrequency High-resolution linear transducer (Bothell, WA, USA) with Sono-Calc IMT software was used for taking automatic measurements of cIMT. This was achieved by averaging three measurements taken on each carotid artery (anterior, lateral and posterior directions) and measuring the distance between the leading edge of the lumen–intima interface and the leading edge of the collagenous upper layer of the adventitia using high-resolution B-mode ultrasonography.
Renal assessment.
Kidney damage was assessed by measuring the serum concentrations of creatinine, which is measured by the enzymatic method, traceable to the isotope dilution mass spectrometry. The estimated glomerular filtration rate (eGFR) was calculated using a modified version of the Modification of Diet in Renal Disease (MDRD) equation based on data from Chinese CKD patients[15].
Other data collection.
We collected urine samples from 7 am to 7 am the next day to detect the extent of proteinuria and sodium levels over 24 h. These patients were asked to void their bladders at 7 am. Proteinuria was measured by immunoturbidimetry. In addition, medical history, including demographic and laboratory data [hemoglobin, albumin, globulin, calcium, phosphate, intact parathyroid hormone (iPTH), serum fasting glucose, cholesterol, triglycerides (TGs), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), homocysteine, uric acid, serum cystatin C, blood urea nitrogen (BUN)] were obtained at the initial study visit. All these experimental data were measured using a 7180 Biochemistry Auto-analyzer (Hitachi, Tokyo, Japan).
Definitions
The diagnosis of hypertension was based on accepted criteria for ABPM [16]: Ambulatory hypertension was defined as mean 24-h BP >130/80 mmHg for SBP/DBP. “Daytime” and “night-time” were defined as the clock time intervals from 7 am to 10 pm and from 10 pm to 7 am, respectively. BP load was the percentage of BP values reaching or exceeding 135 mmHg systolic or 85 mmHg diastolic during day time, or 120 mmHg systolic or 70 mmHg diastolic during night-time [9]. Studies found that SBP load values >50% were correlated significantly with TOD, and values of SBP load >50% might be used to identify severe ambulatory hypertension at risk of TOD [16, 17]. Hence, we used 50% as the cutoff point when we undertook analyses, and patients with BP load >50% were said to have an abnormal BP load.
CKD was defined as the presence of kidney damage or decreased renal function (eGFR of <60 mL/min per 1.73 m2) for ≥3 months according to guidelines set by the Kidney Disease Outcomes Quality Initiative [18].
Diabetes mellitus (DM) was defined as the need for anti-diabetic drugs or meeting the diagnostic criteria for DM specified by chinese guidelines for diabetes prevention and treatment [19]
Statistical analyses
Continuous variables are the mean ± standard deviation (SD). Frequency distributions were used for qualitative variables. Non-parametric variables are expressed as median and interquartile ranges. Log transformation for the eGFR was done in view of the skewed distribution of these data. Comparisons for continuous variables between groups were tested by the Student’s t test or non-parametric test. Differences among categorical variables were analyzed using the χ2 test or the two-tailed Fisher’s exact test, as appropriate. The relationship between two continuous variables was assessed by a bivariate correlation method (Pearson’s correlation).
Univariate linear regression models (enter method) were used to study the association of TOD (LVMI, cIMT, log eGFR, and log proteinuria) and BP load (daytime SBP load and DBP load, night-time SBP load and DBP load), DM (1 = no, 2 = yes), triglycerides (TG), low-density lipoprotein-cholesterol (LDL-C), cholesterol, hemoglobin, albumin (ALB), eGFR, calcium, phosphorus, body mass index (BMI), 24-h SBP and 24-h DBP respectively. To further study the association of 24-BP level, BP load and TOD, multivariate linear regression analysis were performed (stepwise method) which adjusted for age, sex (1 = female, 2 = male), current smoker (1 = no, 2 = yes), alcohol intake (1 = no, 2 = yes) and those variables with a significant association with a dependent variable in the univariate linear regression. In the next step of the analysis, we added BP load (only the BP load which P<0.05 in model 2) to model 3 which already including the 24-h BP (only the BP which P<0.05 in model 2) and other covariables. We tested whether BP load was able to additionally explain the variance of TOD. All values are two-tailed. p<0.05 was considered significant. Data were analyzed using SPSS v18.0 (IBM, Armonk, NY, USA)
Results
Baseline characteristics of CKD patients
A total of 1219 CKD patients were enrolled in this study. The mean age was 44.0±16.6. The male:female ratio was 723:496, which comprised 432 non-diabetic CKD patients without hypertension, 565 non-diabetic CKD patients with hypertension and 222 diabetic patients (18.2%).
Hypertensive non-diabetic CKD patients were older, a higher percentage of smokers and alcohol consumers, higher BMI, higher 24h BP and BP load, higher fasting glucose, cholesterol, LDL-C, calcium, phosphate, creatinine, PTH levels, lower eGFR and hemoglobin, higher LVMI and cIMT compared with non-diabetic CKD patients without hypertension(p<0.05). While diabetic patients were older, a higher percentage of smokers and alcohol consumers, higher BMI, higher 24h BP and BP load, higher fasting glucose, cholesterol, LDL-C, calcium, phosphate, creatinine, PTH levels, lower eGFR and hemoglobin, higher LVMI and cIMT (p<0.05) compared with non-diabetic CKD patients without hypertension(p<0.05). Compared with diabetic CKD patients with hypertension, diabetic patients were older and had: higher BMI, higher BP load and 24h DBP levels, higher fasting glucose, cholesterol, LDL-C, creatinine, PTH levels, lower eGFR and hemoglobin, higher cIMT (p<0.05) compared with non-diabetic CKD patients without hypertension(p<0.05) (Table 1).
Correlation between BP load and TOD in CKD patients
Univariate correlation analyses showed that daytime SBP load, night-time BP load and 24h BP levels correlated with LVMI, cIMT and eGFR in non-diabetic CKD patients without hypertension (p<0.05), while only 24h SBP, rather than BP load, was associated with proteinuria in these patients. BP load and 24h BP levels were significantly related to LVMI and eGFR (p<0.05), SBP load and 24h SBP levels correlated with cIMT (p<0.05), while no correlation was found between BP load and proteinuria in non-diabetic CKD patients with hypertension (Table 2).
SBP load and 24h SBP correlated with LVMI (p<0.05), daytime SBP load, nighttime BP load and 24h SBP correlated with eGFR (p<0.05), BP load and 24h BP levels correlated with proteinuria (p<0.05), while no correlation was found between BP load and cIMT in diabetic patients (Table 3).
Associations of TOD with BP Level or BP Load
In multivariable-adjusted analysis, model 1 without BP load inclusion: 24-h SBP was associated with LVMI, cIMT, proteinuria, while 24-h DBP correlated with eGFR in non-diabetic CKD patients without hypertension. model 2 without 24-h BP inclusion: nighttime SBP load correlated with LVMI, cIMT, proteinuria, while nighttime DBP correlated with eGFR in these patients. Model 3 with aforementioned covariables and both 24h-BP and BP load (p<0.05) in model 1 and model 2 inclusion, nighttime SBP load was able to additionally explain the variance of LVMI and proteinuria in these patients (R2 = 0.034, P<0.001 and R2 = 0.012, P = 0.006 respectively) (Table 4).
In multivariable-adjusted analysis, model 1 without BP load inclusion: 24-h SBP was associated with LVMI, while 24-h DBP correlated with eGFR and proteinuria in non-diabetic CKD patients with hypertension. model 2 without 24-h BP inclusion: SBP load correlated with LVMI, nighttime SBP load correlated with cIMT, nighttime BP load is associated with eGFR, while nighttime DBP load correlated with proteinuria in these patients. Model 3 with aforementioned covariables and both 24h-BP and BP load (p<0.05) in model 1 and model 2 inclusion, nighttime SBP load was able to additionally explain the variance of LVMI, cIMT and eGFR in these patients (R2 = 0.008, P = 0.037, R2 = 0.016, P = 0.011 and R2 = 0.009, P < 0.001 respectively (Table 5).
In multivariable-adjusted analysis, model 1 without BP load inclusion: 24-h SBP was associated with LVMI, eGFR and proteinuria in diabetic CKD patients; model 2 without 24-h BP inclusion: daytime SBP load correlated with LVMI and proteinuria, while nighttime SBP load correlated with eGFR; model 3 with aforementioned covariables and both 24h-BP and BP load (p<0.05) in model 1 and model 2 inclusion, the inclusion of BP load cannot additionally explain the variance of LVMI, cIMT, proteinuria and eGFR in these patients (P>0.05) (Table 6).
Discussion
The present study showed both ambulatory blood pressure and BP load were independent associated with TOD in CKD patients, furthermore, nighttime SBP load was able to additionally explain the variance of TOD in non-diabetic CKD patients. In this regard, nighttime BP load correlated with TOD in non-diabetic CKD patients was not fully dependent 24-h BP levels. According to our best knowledge, this is the first study to show the relationship between BP load and cardiac, large vascular, and renal damage in CKD patients. Our study suggested that nighttime SBP load might play a role in non-diabetic CKD patients.
One study from 8711 subject showed that BP load did not improve risk stratification based on 24-hour BP level even in patients without hypertension [20]. However, there are no data on the relationship between BP load and TOD in CKD patients dependent on the BP level or not. CKD patients are considered to be the “highest risk group” for subsequent cardiovascular vascular disease (CVD) events, and treatment recommendations based on stratification of CVD risk should take into account the highest-risk status [21]. We could not speculate any conclusion based on results from the general population, even patients with hypertension. In this study, we enrolled more than 1000 CKD patients, separated patients with hypertension and diabetic mellitus or not, and undertook a comprehensive assessment of these patients. We found that nighttime SBP load might be a new risk factor, independent of BP levels, for TOD in non-diabetic CKD patients, whereas no significant relationship was found in diabetic CKD patients.
Current therapy to retard the progression of CKD has yielded disappointing outcomes despite aggressive control of BP. Parameters currently used to assess the adequacy of BP control need to be reassessed [22]. BP is fundamentally labile even in the normotensive state, and it is the intact auto-regulatory mechanisms that prevent the normally occurring BP fluctuations from target organs [23]. Therefore, if auto-regulation is impaired, there is greater transmission of such BP lability to target organs, and pressure exposed to these organs might not be normalized even if overall normal BP is achieved with antihypertensive therapy. In this context, the percentage of ABPM above threshold values has been termed as “BP load” and suggested to be a clinically useful parameter complementing quantification of average ABP levels, which might be an index of hemodynamic burden on the cardiovascular system in addition to the information carried by average ABP levels [24, 25]. We should identify CKD patients even with a significantly increased BP load so that special implementation can be used not only to lower BP levels but also to normalized BP load and prevent subclinical organ damage. Any patient with a higher BP load means that key organs such as the heart and kidney as well as large arteries are exposed to higher pressure for a longer duration even if the mean BP is normal. Patients with increased nighttime BP load means overloading the cardiovascular system, with the consequent negative impact on the heart and vascular structures. Consequently, a higher night-time BP load affects the heart, vasculature, and kidneys, boosting damage and increasing the risk of developing clinical events [26].
Diabetes mellitus is an established risk factor for coronary heart disease and ischemic stroke. It confers an approximate two fold increased risk for a wide range of vascular diseases compared with non-diabetic patients [27]. Diabetic patients have a significantly higher night-time systolic BP and reduced night-time variability of heart rate than those without diabetes [28]. Another fact that diabetic CKD patients have worse control of SBP, higher prevalence of a non-dipping pattern, and cardiovascular disease compared with non-diabetic CKD patients [29, 30]. All these data would lead to different results of ambulatory BP and TOD compared with non-diabetic patients. Our results showed different role of BP load in CKD patients with diabetic or non-diabetic: night-time SBP load correlated with LVMI, proteinuria in non-diabetic CKD patients without hypertension and correlated with LVMI, cIMT and eGFR in non-diabetic CKD patients with hypertension, while BP load did not refine this correlation based on the 24-h BP level in diabetic CKD patients. All these data suggested different role of BP load in diabetic and non-diabetic patients might be related to the complicated conditions in diabetic patients.
In our current study, the correlation coefficients between level and load were all >0.6, multiple regression analysis which include both level and load to assess the independent effect of a single variable may be misleading because of multicollinearity. To avoid the effect of multicollinearity, 24h-BP and load were included in model 1 and model 2 respectively by multivariable-adjusted analysis. In the next step, to investigate whether the correlations between BP load and TOD were over and beyond the 24-h BP level. We added significantly associated BP load to model 3 which already including the significantly associated 24-h BP and other covariables and computed the R squared change and p value.
This study had limitations that should be considered when evaluating our results. Firstly, because of the cross-sectional design of the study, we could not establish a causal relationship between BP load and TOD, but merely observe an association. Secondly, drug would not have affected the result of analyses since patients who received any antihypertensive drug in the previous month were excluded. However, we could not rule out the effect of chinese medicines. Thirdly, all CKD patients were admitted to our hospital division. Actually, these patients had severe proteinuria or severe renal damage, so some CKD patients with non-severe proteinuria or non-severe renal damage might have been omitted, which lead to some difference from general CKD patients. Therefore, further multi-center, larger-sample follow-up studies are necessary to explore the relationship between BP load and TOD.
In conclusion, our analyses showed that BP level and load were both independently associated with TOD. However, adding BP load to models already including BP level was able to additionally explain the variance of TOD in non-diabetic CKD patients. Our study provides important information that BP load might be an independent risk factor for cardiac, large vascular and renal damages in non-diabetic CKD patients, and we should undertake comprehensive assessment of BP in the management of non-diabetic CKD patients.
Acknowledgments
We would like to thank all patients and their families for participating in this study.
Author Contributions
Conceived and designed the experiments: CW TQL JZ. Performed the experiments: CW JZ WJD WYG HP ZCY. Analyzed the data: CW JZ WJD. Contributed reagents/materials/analysis tools: XL JZ. Wrote the paper: CW TQL JZ.
References
- 1. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 379:815–822. pmid:22386035
- 2. Bakris GL, Ritz E (2009)World Kidney Day Steering Committee: the message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. J Clin Hypertens (Greenwich) 11144–147.
- 3. Ptinopoulou AG, Pikilidou MI, Lasardis AN (2013) The effect of antihyperten- sive drugs on chronic kidney disease: a comprehensive review. Hypertens Res36:91–101. pmid:23051659
- 4. Bliziotis IA, Destounis A, Stergiou GS (2012) Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens301289–1299. pmid:22499289
- 5. Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F (2013) Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol Int30:17–30. pmid:23002916
- 6. Bostanci BK, Civilibal M, Elevli M, Duru NS (2012) Ambulatory blood pressure monitoring and cardiac hypertrophy in children with metabolic syndrome. Pediatr Nephrol27:1929–1935. pmid:22610040
- 7. Sharma AP, Mohammed J, Thomas B, Lansdell N, Norozi K, Filler G (2013) Nighttime blood pressure, systolic blood pressure variability,and left ventricular mass index in children with hypertension. Pediatr Nephrol28:1275–1282. pmid:23564040
- 8. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, et al. (2007) Hypertensive Subjects Awake Systolic Blood Pressure Variability Correlates With Target-Organ Damage in hypertensive subjects. Hypertension.;50:325–332. pmid:17562971
- 9. Zachariah PK, Sheps SG, Bailey KR, Wiltgen CM, Moore AG (1991) Age- related characteristics of ambulatory blood pressure load and mean blood pressure in normotensive subjects. JAMA 265:1414–1417. pmid:1999882
- 10. White WB (1991) Blood pressure load and target organ effects in patients with essential hypertension. J Hypertens; 9:S39 –S41.
- 11. Liu M, Li Y, Wei FF, Zhang L, Han JL, Wang JG (2013) Is blood pressure load associated, independently of blood pressure level, with target organ damage? J Hypertens;31:1812–1818. pmid:23743810
- 12. Wang C, Zhang J, Liu X, Li C, Ye Z, Peng H, et al. (2013) Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One8(2):e55419. pmid:23393577
- 13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparsion to necropsy findings. Am J Cardiol, 57:450–458. pmid:2936235
- 14. European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21:1011–1053. pmid:12777938
- 15. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. (2006) Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease. J Am Soc Nephrol. 17:2937–2944. pmid:16988059
- 16. Sorof JM, Cardwell G, Franco K, Portman RJ (2002) Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 39:903–908. pmid:11967247
- 17. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. (2008) American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research.Hypertension52:433–451. pmid:18678786
- 18. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 139:137–147. pmid:12859163
- 19. The Department of Disease Control, Ministry of Health, China, the Chinese Diabetes Society (2004),The Chinese guideline of diabetes prevention and treatment, Chin. J. Prev.Control Chron. Non-commun. Dis12283–285.
- 20. Li Y, Thijs L, Boggia J, Asayama K, Hansen TW, Kikuya M, et al. (2014) International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification.Hypertension63:925–933. pmid:24535008
- 21. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. (2003) Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseA Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation1082154–6922. pmid:14581387
- 22. Bidani AK, Griffin KA, Epstein M (2012) Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med1251057–1062. pmid:22906957
- 23. Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R (2009) Protective importance of the myogenic response in the renal circulation. Hypertension54:393–398. pmid:19546375
- 24. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. (2005) European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 23:697–701. pmid:15775768
- 25. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. (2008) American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension52:433–451. pmid:18678786
- 26. Draws PE, Rosenthal N, Babineau DC, Rahman M (2010) Nighttime Hospital Blood Pressure–a Predictor of Death, ESRD,and Decline in Glomerular Filtration Rate. Ren Fail 32: 1036–1043. pmid:20863206
- 27. Emerging risk factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222. pmid:20609967
- 28. Tamura K, Yamauchi J, Tsurumi-ikeya Y, Sakai M, Ozawa M, Shigenaga A, et al. (2008) Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparsion between diabetic nephropathy and non-diabetic glomerulopathy. Clin Exp Hypertens30:33–43. pmid:18214732
- 29. Li J, Wang F, Jian G, Ma N, Fan Y, Yu G, et al. (2013) Analysis of 24-h ambulatory blood pressure monitoring in patients with diabetic nephropathy: a hospital-based study. Clin Nephrol 79:199–205. pmid:23110771
- 30. van der Meer IM, Ruggenenti P, Remuzzi G (2010) The diabetic CKD patients- a major cardiovascular challenge. J Ren Care,36:s34–36.